関連する実験動画
Updated: Sep 10, 2025

05:49
Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
Published on: May 5, 2021
5.0K
SP1活性化されたCFL2は,高グルコース誘発の網膜色素上皮細胞損傷を促進し,AMPK/mTOR経路を関与させる
Jinan Xiao1, Jingni Yu1, Mei Ren1
1Department of Ophthalmology, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, China.
Journal of diabetes investigation
|August 26, 2025
まとめ
コフィリン-2 (CFL2) は,SP1/AMPK/mTOR経路を通じて網膜の皮質細胞損傷を促進することによって,糖尿病性網膜症 (DR) を悪化させる. CFL2をターゲットにすることで DRの潜在的な治療戦略が提供されます.
科学分野:
- 分子生物学
- 細胞生物学
- 眼科について
背景:
- コフィリン-2 (CFL2) は,筋肉細胞のアクチンホメオスタシスに不可欠なアクチン結合タンパク質である.
- CFL2は糖尿病性網膜病変 (DR) の進行に関与しているが,その正確な役割とメカニズムはさらなる解明を必要としている.
研究 の 目的:
- 高グルコース誘発の網膜色素上皮細胞 (RPE) 損傷におけるコフィリン-2 (CFL2) の役割とメカニズムを調査する.
- 特殊タンパク質1 (SP1) とCFL2の規制関係をDRの文脈で探求する.
主な方法:
- 網膜色素上皮細胞 (ARPE-19) は高グルコース条件下で培養された.
- 細胞増殖,アポトーシス,酸化ストレス,フェロプトーシス,炎症を評価した.
- CFL2とSP1のmRNAとタンパク質レベルを定量化し,その相互作用と経路の関与 (AMPK/mTOR) を分析した.
主要な成果:
- 高グルコース誘発のRPE細胞損傷は,増殖抑制とアポトーシスの増加,酸化ストレス,フェロプトーシス,および炎症によって特徴付けられます.
- CFL2を静止すると高血糖によるRPE細胞損傷が軽減される.
- SP1はCFL2の発現を直接上調し,SP1のノックダウンはCFL2レベルを低下させ,AMPK/mTOR経路を抑制することでRPE細胞損傷を軽減した.
結論:
- SP1で活性化されたCFL2は,AMPK/mTOR経路を調節することにより,高グルコース誘発のRPE細胞損傷を促進します.
- CFL2は糖尿病性網膜症の管理のための潜在的な治療目標です.
関連する概念動画
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Cell Specific Gene Expression
13.9K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.9K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K

